Data-driven trends show increased FDA authorization of PCCPs, enhancing SaMD compliance and postmarket change controls.

Yu Zhao delivered a plenary lecture and hosted workshops on FDA regulations at the International Regulatory Science Forum 2024.

This article deciphers the new U.S. laws around Predetermined Change Control Plans (PCCP).

This white paper provides a comprehensive analysis of the PCCP, along with practical insights into implementation priorities and approaches